Curanex Pharmaceuticals Inc — Investor Relations & Filings
Filings indexed
56
across all filing types
Latest filing
2026-05-14
Regulatory Filings
Country
US
United States of America
Listing
US
CURX
Curanex Pharmaceuticals Inc. is a developmental-stage pharmaceutical company focused on the discovery, development, and commercialization of innovative botanical drugs. The company's primary efforts are directed towards creating treatments for patients suffering from inflammatory diseases, with a particular emphasis on developing therapies for moderate to severe ulcerative colitis. Its research platform has also validated effects in animal models for other inflammatory conditions, including atopic dermatitis and COVID-19.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-14 | English | |
| 10-Q | 2026-05-14 | English | |
| 8-K - Curanex Pharmaceuticals Inc (0002025942) (Filer) | 2026-05-07 | English | |
| 8-K - Curanex Pharmaceuticals Inc (0002025942) (Filer) | 2026-04-02 | English | |
| 10-K - Curanex Pharmaceuticals Inc (0002025942) (Filer) | 2026-03-30 | English | |
| 8-K | 2026-01-05 | English |
Browse filings by year
3 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 46026259 | 8-K | 2026-05-14 | English | ||
| 46026352 | 10-Q | 2026-05-14 | English | ||
| 43150861 | 8-K - Curanex Pharmaceuticals Inc (0002025942) (Filer) | 2026-05-07 | English | ||
| 33155410 | 8-K - Curanex Pharmaceuticals Inc (0002025942) (Filer) | 2026-04-02 | English | ||
| 33093367 | 10-K - Curanex Pharmaceuticals Inc (0002025942) (Filer) | 2026-03-30 | English | ||
| 13706981 | 8-K | 2026-01-05 | English | ||
|
2025
9 filings
| |||||
| 13706982 | 10-Q | 2025-11-15 | English | ||
| 13706983 | NT 10-Q | 2025-11-15 | English | ||
| 13706984 | 8-K | 2025-11-06 | English | ||
| 13706985 | 8-K | 2025-09-29 | English | ||
| 13706986 | 8-K | 2025-09-12 | English | ||
| 13706987 | 10-Q | 2025-09-09 | English | ||
| 13706991 | 3 | 2025-09-03 | English | ||
| 13706988 | 3 | 2025-09-03 | English | ||
| 13706989 | 3 | 2025-09-03 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BioNTech SE
Biotechnology company developing immunotherapies for cancer…
|
BNTX | DE | Manufacturing |
|
BioNxt Solutions Inc.
Clinical-stage developer of next-generation drug formulatio…
|
BNXT | CA | Manufacturing |
|
Biophage Pharma Inc.
Developing innovative phage-based therapies for antibiotic-…
|
BIPMF | CA | Manufacturing |
|
BioPorto
An in vitro diagnostics company specializing in biomarkers …
|
BIOPOR | DK | Manufacturing |
|
BIO-RAD LABORATORIES, INC.
Develops and manufactures products for life science and cli…
|
BIO | US | Manufacturing |
|
Biosergen AB
Develops drugs to treat severe and resistant invasive funga…
|
BIOSGN | SE | Manufacturing |
|
Biosino Bio-Technology and Science Incorporation
Major high-tech manufacturer of in-vitro diagnostic (IVD) p…
|
8247 | HK | Manufacturing |
|
BIOSIS GROUP BERHAD
Manufacturer of pharmaceutical, personal care, skincare, an…
|
— | MY | Manufacturing |
|
Bio Solution Co.,Ltd.
Develops cell therapies, human tissue models, and bio-labor…
|
086820 | KR | Manufacturing |
|
BioSyent Inc.
Specialty pharmaceutical company developing and commerciali…
|
RX | CA | Manufacturing |
Curanex Pharmaceuticals Inc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34928/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34928 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34928 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34928 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34928}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Curanex Pharmaceuticals Inc (id: 34928)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.